EHC·Encompass Health Corporation
EHC|Analyst Targets
EHC|Insider Trading
EHC|Fundamentals
EHC|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.36 | - | - |
| Q3'25 | $1.19 | $1.23 | +3.2% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.6B | - | - |
| Q3'25 | - | $1.5B | - |
EHC|Monthly Returns
Market Data
EHC Stock Snapshot
- Market cap
- 12.06B
- P/E ratio
- 19.4
- Day range
- $120.98 – $124.90
- News sentiment
- 64/100 · Bullish
- Analyst target
- $148.17 (+18.8%)
- Consensus
- Buy · 20 analysts
The technical read on EHC is balanced, which usually means the market is waiting on a catalyst. Earnings and guidance carry more weight than macro data at this capitalisation.
Reverse DCF
What growth is priced into EHC?
At today's price, Encompass Health Corporation needs to grow free cash flow about 11.6% a year for the next 10 years to justify its valuation at a 7.11% cost of capital. Over its actual history it has compounded free cash flow at 1.0% a year, so the market is asking for 10.6 percentage points above its own delivered rate. On that basis EHC looks priced above what its own growth record supports.
- Implied FCF growth
- 11.6%
- Historical FCF CAGR
- 1.0%
- Growth gap
- +10.6 pts
- Verdict
- RICH
- Discount rate (WACC)
- 7.11%
- Beta
- 0.49
Behaviour On Record
What EHC's own history says about today's numbers
- Realized volatility (21d)
- 17.2% 20th pct
- Below its peak
- -4.9%
- vs 200-day average
- +11.7%
- Up days (1y)
- 46%
Encompass Health Corporation is currently running 17.2% annualised volatility over the last 21 sessions. Measured against EHC's own 13 years of daily returns rather than a market-wide average, that is the 20th percentile — unusually subdued by its own history, against a typical reading of 23.6%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
EHC is trading -4.9% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -17.5%, and the deepest was -39.5% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +11.7% from its 200-day moving average. Against every other day in its history, that gap ranks at the 69th percentile — a somewhat wider gap than its own norm. Over the past year EHC closed higher on 46% of sessions, and it is currently 2 sessions into a rising streak.
On October specifically: over 13 years of records, EHC finished the month higher 5 of 13 times, with a median return of -0.4% and an average of -1.5%. Its strongest month historically has been April at +6.7% on average, its weakest December at -2.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: EHC has opened more than 2% away from the prior close in 112 of 3,267 sessions (3.4% of the time), with the largest gaps running +10.9% and -17.1%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,268 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against EHC's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of EHC's sector?
Encompass Health Corporation sits in the Health Care sector, currently ranked 8th of 12 GICS sectors by relative-strength rotation score (lagging).
- Sector rank
- #8 of 12
- Sector state
- Lagging
- Sector rotation score
- 0
Analyst Rating Changes
Are analysts turning bullish or bearish on EHC?
TD Cowen most recently reiterated its rating on Encompass Health Corporation to Buy on Aug 10, 2026 with a price target of $140 (from $125). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- TD Cowen — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Held by These ETFs
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Citadel Advisors LLC | • Hold | 2,623,804 | 2.71% | $265.21M | 2026-09-02 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-31 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-10-30 | 2025-11-21 |